Find similar content

Source channel @githubtrending · Post #14925 · Jul 7

#typescript#12_factor#12_factor_agents#agents#ai#context_window#framework#llms#memory#orchestration#prompt_engineering#rag The 12-Factor Agents are a set of proven principles to build reliable, scalable, and maintainable AI applications powered by large language models (LLMs). They help you combine the creativity of AI with the stability of traditional software by managing prompts, context, tool calls, error handling, and human collaboration effectively. Instead of relying solely on complex frameworks, you can apply these modular concepts to improve your existing products quickly and reach high-quality AI performance for real users. This approach makes AI software easier to develop, debug, and scale, ensuring it works well in production environments[1][3][5]. https://github.com/humanlayer/12-factor-agents

Hashtags

#typescript #12_factor #12_factor_agents #agents #ai #context_window #framework #llms #memory #orchestration #prompt_engineering #rag

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment